pαH-rS2d-HexaPro
(Plasmid
#183515)
-
PurposeMammalian cell expression of SARS-CoV-2 Spike protein rS2d-HexaPro with (682-685) furin side replaced with GSAS and mutation S383C, D985C, F817P, A892P, A899P, A942P, K986P,V987P
-
Depositing Lab
-
Depositing OrganizationDuke University
Located in United States of America -
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 183515 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
| DNA | 183515-D50 | 50 μg of DNA in Tris buffer | $495 | ||
| DNA | 183515-D100 | 100 μg of DNA in Tris buffer | $585 | ||
Backbone
-
Vector backbonepαH
- Backbone size w/o insert (bp) 4746
- Total vector size (bp) 8370
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameSpike (S-GSAS-rS2d.HexaPro)
-
Alt namepαH-S-GSAS-rS2d.HexaPro
-
SpeciesSevere acute respiratory syndrome coronavirus 2
-
Insert Size (bp)3624
-
MutationEctodomain (AAs 1-1208); 682-685 (furin site = RRAR) replaced with GSAS; S383C, D985C, F817P, A892P, A899P, A942P, K986P,V987P
-
Entrez GeneS (a.k.a. GU280_gp02, spike glycoprotein)
-
Tags
/ Fusion Proteins
- HRV3C cleavage site (C terminal on backbone)
- 8X His tag (C terminal on backbone)
- 2X Strep-Tag II (C terminal on backbone)
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer Unknown
- (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byA portion of this plasmid was derived from a plasmid made by Jason McLellan; https://www.addgene.org/164566/.
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://www.biorxiv.org/content/10.1101/2022.01.25.477784v1 for bioRxiv preprint.
DNA (Catalog # 183515-D50)
Purpose
Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.
Delivery
- Amount 50 μg
- Concentration 1 μg/μL
- Pricing $495 USD
- Storage 4 ℃ (short-term) or -20 ℃ (long-term)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Quality Control
Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.
Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.
DNA (Catalog # 183515-D100)
Purpose
Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.
Delivery
- Amount 100 μg
- Concentration 1 μg/μL
- Pricing $585 USD
- Storage 4 ℃ (short-term) or -20 ℃ (long-term)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Quality Control
Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.
Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pαH-rS2d-HexaPro was a gift from Priyamvada Acharya (Addgene plasmid # 183515 ; http://n2t.net/addgene:183515 ; RRID:Addgene_183515) -
For your References section:
Structural diversity of the SARS-CoV-2 Omicron spike. Gobeil SM, Henderson R, Stalls V, Janowska K, Huang X, May A, Speakman M, Beaudoin E, Manne K, Li D, Parks R, Barr M, Deyton M, Martin M, Mansouri K, Edwards RJ, Eaton A, Montefiori DC, Sempowski GD, Saunders KO, Wiehe K, Williams W, Korber B, Haynes BF, Acharya P. Mol Cell. 2022 Jun 2;82(11):2050-2068.e6. doi: 10.1016/j.molcel.2022.03.028. Epub 2022 Mar 25. 10.1016/j.molcel.2022.03.028 PubMed 35447081